Norges Bank Invests $20.67 Million in ICU Medical, Inc. (NASDAQ:ICUI)

Norges Bank purchased a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUIFree Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 207,230 shares of the medical instruments supplier’s stock, valued at approximately $20,669,000. Norges Bank owned about 0.86% of ICU Medical at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Swiss National Bank raised its position in shares of ICU Medical by 1.1% in the third quarter. Swiss National Bank now owns 45,019 shares of the medical instruments supplier’s stock valued at $5,358,000 after purchasing an additional 500 shares during the period. Gamco Investors INC. ET AL grew its stake in ICU Medical by 1.1% in the 3rd quarter. Gamco Investors INC. ET AL now owns 24,950 shares of the medical instruments supplier’s stock valued at $2,969,000 after buying an additional 278 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in ICU Medical by 7.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 168,957 shares of the medical instruments supplier’s stock valued at $20,108,000 after acquiring an additional 11,364 shares during the period. Campbell & CO Investment Adviser LLC lifted its position in shares of ICU Medical by 148.9% during the third quarter. Campbell & CO Investment Adviser LLC now owns 12,670 shares of the medical instruments supplier’s stock worth $1,508,000 after acquiring an additional 7,580 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D lifted its position in shares of ICU Medical by 27.3% during the third quarter. State of New Jersey Common Pension Fund D now owns 16,913 shares of the medical instruments supplier’s stock worth $2,013,000 after acquiring an additional 3,631 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, KeyCorp lifted their price target on ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research report on Wednesday, February 28th.

View Our Latest Report on ICUI

ICU Medical Trading Up 2.7 %

Shares of ICU Medical stock opened at $106.34 on Monday. The company’s 50-day moving average price is $101.45 and its 200-day moving average price is $98.26. The company has a market cap of $2.59 billion, a price-to-earnings ratio of -43.40 and a beta of 0.72. ICU Medical, Inc. has a 12-month low of $78.28 and a 12-month high of $196.57. The company has a current ratio of 2.61, a quick ratio of 1.09 and a debt-to-equity ratio of 0.76.

ICU Medical (NASDAQ:ICUIGet Free Report) last posted its earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.06. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. The business had revenue of $566.66 million for the quarter, compared to analysts’ expectations of $553.15 million. On average, equities analysts expect that ICU Medical, Inc. will post 3.5 earnings per share for the current fiscal year.

Insider Buying and Selling

In other ICU Medical news, insider Ben Sousa sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $105.55, for a total value of $211,100.00. Following the sale, the insider now owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other ICU Medical news, VP Daniel Woolson sold 791 shares of ICU Medical stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the sale, the vice president now owns 13,980 shares of the company’s stock, valued at $1,373,814.60. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Ben Sousa sold 2,000 shares of the company’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $105.55, for a total value of $211,100.00. Following the completion of the transaction, the insider now owns 1,319 shares of the company’s stock, valued at $139,220.45. The disclosure for this sale can be found here. Insiders sold a total of 25,498 shares of company stock worth $2,633,440 over the last ninety days. 6.70% of the stock is owned by corporate insiders.

ICU Medical Company Profile

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Read More

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIFree Report).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.